IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $962,309 | -0.4% | 60,638 | +18.4% | 0.00% | -50.0% |
| Q2 2023 | $966,170 | +295.3% | 51,202 | -19.6% | 0.00% | – |
| Q1 2023 | $244,412 | -27.3% | 63,650 | -6.3% | 0.00% | -100.0% |
| Q4 2022 | $336,248 | -10.3% | 67,912 | -13.6% | 0.00% | 0.0% |
| Q3 2022 | $375,000 | +3.3% | 78,647 | -2.5% | 0.00% | 0.0% |
| Q2 2022 | $363,000 | -31.1% | 80,636 | -9.4% | 0.00% | 0.0% |
| Q1 2022 | $527,000 | -27.8% | 89,027 | -9.5% | 0.00% | 0.0% |
| Q4 2021 | $730,000 | +48.4% | 98,339 | +13.3% | 0.00% | 0.0% |
| Q3 2021 | $492,000 | -15.3% | 86,788 | -1.7% | 0.00% | 0.0% |
| Q2 2021 | $581,000 | -22.0% | 88,305 | -3.9% | 0.00% | -50.0% |
| Q1 2021 | $745,000 | +25.6% | 91,906 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $593,000 | +68.0% | 92,102 | -6.0% | 0.00% | +100.0% |
| Q3 2020 | $353,000 | -20.7% | 97,957 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $445,000 | +36.9% | 96,848 | +1.8% | 0.00% | 0.0% |
| Q1 2020 | $325,000 | – | 95,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |